First-to-market launch of Sugammadex Injection

With the first-to-market launch of Sugammadex Injection, a generic equivalent of Bridion®, in the U.S., we continue expanding our hospital portfolio, reinforcing our commitment to improving patient access to affordable and high-quality medicines.